Transvaginal color Doppler determination of the ovarian and uterine blood flow characteristics in polycystic ovary disease

Size: px
Start display at page:

Download "Transvaginal color Doppler determination of the ovarian and uterine blood flow characteristics in polycystic ovary disease"

Transcription

1 FERTILITY AND STERILITY Copyright < American Society for Reproductive Medicine Printed on acid-free paper in U. S. A. Transvaginal color Doppler determination of the ovarian and uterine blood flow characteristics in polycystic ovary disease Fatma A. Aleem, M.D., Ph.D.* Mladen Predanic, M.D., M.sc. Division of Reproductive Endocrinology and Infertility, Department of Obstetrics and Gynecology, The Brookdale Hospital Medical Center, Brooklyn, New York Objective: To determine blood flow characteristics of ovarian and uterine arteries in patients with endocrinologically and clinically confirmed polycystic ovary disease (PCOD) in comparison with blood flow parameters observed in patients with spontaneous ovulatory cycles. Design: Controlled clinical study. Setting: Patients from Infertility Service in a tertiary care institution. Patients: Forty patients with confirmed PCOD and 50 control patients in various phases of spontaneous menstrual cycles. Main Outcome Measure: Using transvaginal color Doppler sonography to determine ovarian morphology, ovarian blood vessel visualization rates, and ovarian and uterine arteries blood flow parameters (resistance index, pulsatility index, and maximal peak velocity). These parameters were correlated with serum hormone levels. Results: Polycystic ovaries showed typical vascular pattern: increased stromal vascularity, a positive correlation between increased blood velocities and serum LH levels, and a trend toward lower resistance index and pulsatility index values, whereas uterine arteries revealed significantly increased resistance index and pulsatility index values. Conclusions: The observed specific intraovarian and uterine vascular pattern in PCOD patients may provide additional data for conventional endocrinologic and ultrasonic diagnostic methods for PCOD. Fertil Steril 1996;65:510-6 Key Words: Polycystic ovary, color Doppler, ovarian and uterine blood flow Polycystic ovary disease (PCOD) is a topic likely to generate greater controversy about etiology or pathogenesis than any other disease in gynecological endocrinology. Polycystic ovary disease remains an enigma because of the superficial nature of our knowledge regarding its etiology and the pathophysiology. However, several subgroups ofpcod caused by hypothalamic-pituitary, ovarian, or adrenal steroidogenic defects can be distinguished. Polycystic ovary disease, ultrasonically characterized by commonly enlarged ovaries with increased numbers of small follicles interspersed by abundant stroma (1), is a consequence of broad spectrum in hormone imbalance. Received March 23, 1995; revised and accepted September 29, * Reprint requests: Fatma A. Aleem, M.D., Ph.D., Division of Reproductive Endocrinology and Infertility, Department of Obstetrics and Gynecology, Brookdale Hospital, 1335 Linden Boulevard, Suite 100, Brooklyn, New York (FAX: ). 510 Aleem and Predanic PCO and color flow sonography The hemodynamicity of ovarian and uterine microcirculation is a "marionette" of hormonal changes in general and at local levels. Therefore, transvaginal color Doppler sonography was used in the assessment of uterine and ovarian blood flow changes in normal and stimulated menstrual cycles in correlation with E2 and P serum levels (2-5). Changes in the vasculature of the cycling ovary, described as rapid and profound, suggest that vascularization of the follicles may playa role in their maturation from early follicular phase onward (6-10). However, an increased ovarian vascularity also may reflect a response to specific signals for angiogenesis and/or accelerated metabolism in growing follicles. If it is assumed in PCOD that follicular development and maturation are impaired due to hormone imbalance or vascular impairment, then ovarian vascularity assessment may provide additional information about PCOD pathophysiology and may guide in choosing appropriate hormonal regimen treatment. Therefore, the goal of the present work was to study basic

2 ovarian vasculature and uterine blood flow in PCOD patients, to see if a correlation exists between blood flow data and ovarian morphology or hormone serum levels and to compare PCOD blood flow characteristics with those obtained from spontaneous ovulatory menstrual cycles. MATERIALS AND METHODS A total of 90 women from our Reproductive and Infertility Service, 40 patients with confirmed PCOD and 50 women with spontaneous ovulatory cycles, were included in the present study. The routine workup of our infertility patients consists of a transvaginal sonogram of pelvic organs and laboratory determination of serum hormone concentrations. Regarding the PCOD patients, the mean age of this group was 27.8 years (range 18 to 38 years). A mean body mass index (EM!) was 32.5 :::'::: 1.2 (mean :::'::: SEM). Clinical evidence of hyper androgen ism was noted, while serum levels oflh, FSH, LH:FSH ratio, PRL, T, E2, and P levels, measured in a reliable laboratory using RIA, were done on the same day of transvaginal color Doppler sonography examination. Thirty-seven patients had oligomenorrhea, two had amenorrhoea, and one patient had dysfunctional bleeding. Although, PCOD patients have tonic or steady state of serum hormone levels, patients with oligomenorrhea were examined with transvaginal color Doppler sonography between the 3rd and 8th day of the menstrual cycle to avoid possible interference of corpus luteum presence. The control group of patients with normal menstrual cycles was selected according to ultrasonic findings of normal uteri and ovaries with documented ovulation and menstrual cycle duration of 26 to 32 days for at least the previous 3 months. These patients had normal ovulatory cycles but were diagnosed to be infertile due to tubal or male factors. The mean age was 31.2 years, ranging from 18 to 42 years and the mean BMI was 30.2 :::'::: 2.4. A menstrual cycle was divided into four phases: 3rd to 8th day, 9th to 14th day, 15th to 21st day, and 22nd day to the end of the menstrual cycle. The longest menstrual cycle in the control group of patients was 32 days. This classification was done according to hormonal changes in spontaneous-ovulatory cycle to represent as close as possible hormonal and vascular hemodynamic changes throughout spontaneous ovulatory cycle. It was based upon reports published previously, in which blood flow changes were correlated with the E2 and P serum concentrations (2-5), Along with our standard practice of examining infertility patients with transvaginal conventional so- nography to rule out uterine and ovarian abnormalities, color flow sonography was added to the present study, with the consent of each patient, for the assessment of ovarian and uterine vascularity. A color Doppler ultrasound machine Ultramark 9-HDI (ATL Laboratories, Seattle, WA) with a 5-MHz transvaginal transducer was used. Ovarian volume, number of follicles, and the greatest diameter of the largest follicles were recorded. Ovarian volume was calculated by a simplified formula for a prolate ellipsoid: D1 X D2 X D3 X 0.52, where D1, D2, and D3 represented largest ovarian length, width, and depth diameters. Both right and left ovaries were observed and analyzed in each patient, revealing no statistical significance in morphological parameter values between them for both groups of patients. Therefore, the mean value for all ovarian morphological parameters was calculated and used in the statistical analysis. After the assessment of ovarian morphology, color Doppler was used for demonstrating the main uterine artery and ovarian vascular network within the ovary. The ascending branch ofthe main uterine artery was located in the transversal section, lateral to the uterus at the level of the cervicouterine junction, and ovarian blood vessels were visualized within the ovarian stroma of PCOD ovaries (away from the ovarian surface) or around the preovulatory follicle and corpus luteum in the ovaries of the control group. The lowest color pulsed repetition frequency of 400 Hz with wall filter of 50 to 100 Hz was used to achieve an enhanced blood flow image of the ovarian vascularity. Ovaries were assessed as avascular if no blood flow was demonstrated by color Doppler modality, whereas any blood flow signal, even if only one vessel was visualized, was recognized as a positive finding. After the visualization of blood vessels inside the ovarian stroma, blood flow characteristics were analyzed with pulsed Doppler. The angle of ins on at ion was changed to obtain maximum blood flow velocity and quality of pulsed Doppler signals. For uterine arteries, maximal blood velocity values were corrected by determining the angle between the ultrasound beam and the vessels. However, the angle between ultrasound beam and intraovarian blood vessels was impossible to obtain, therefore, the probe was tilted until the clearest pulsed Doppler waveform was achieved. Obtained pulsed Doppler signals were assessed in terms of blood flow velocities (peak systolic velocity) and vascular impedance to blood flow (resistance index and pulsatility index). When more than one pulsed Doppler signal was detected inside the ovarian stroma, only those waveforms with the lowest vascular impedance to blood flow were selected for Doppler analysis. The means of the resistance index, pulsatility index, and peak systolic velocity values were ob- Aleem and Predanic pea and color flow sonography 511

3 tained for each patient from three consecutive pulsed Doppler waveform signals. Statistical analysis was done by Pearson correlation test for comparison between hormone levels, ovarian morphological parameters, and blood flow data for uterine and ovarian vessels, and by oneway analysis of variance for comparison of measured parameters between PCOD patients and control group. Results were reported as arithmetical mean ± SEM and range of values. RESULTS The hormone serum concentrations obtained from PCOD patients the day oftransvaginal color Doppler examination were as follows: LH, 12.8 ± 2.4 miui ml (conversion factor to SI unit, 1.00); FSH, 5.8 ± 0.6 miu/ml (conversion factor to SI unit, 1.00); T, 50.1 ± 4.5 ng/100 ml (conversion factor to SI unit, 3.46); PRL, 13.5 ± 2.5 ng/ml (conversion factor to SI unit, 2.714); E 2, 92.9 ± 18.6 JLg/L (conversion factor to SI unit, 3.671); and P, 0.6 ± 0.1 JLg/L (conversion factor to SI unit, 3.18). The calculated mean value for the LH:FSH ratio was 2.2 ± 0.5. The mean ovarian volume in PCOD patients was 8 ± 0.7 ml with a range from 3.1 to 19.3 ml, which was significantly larger than ovarian volumes in the follicular phase of the spontaneous cycling ovaries (4.1 ± 0.3; P < 0.01). A significantly larger number of follicles in PCOD ovaries (10 ± 0.7) when compared with early follicular phase of control group (3.3 ± 0.3) also was found (P < 0.01). However, there was no significant difference for the largest diameter ofthe largest follicle between PCOD and sponta neously cycling ovaries. Color Doppler demonstrated an increased vascularity in PCOD ovaries compared with the early follicular phase ofthe ovulatory menstrual cycle. Blood flow visualization rate of 88% for the PCOD group compared with only 50% in normal cycling ovaries in the patients from 3rd to 8th day was found (Fig. 1). A difference in the blood flow pattern also was noted. One prominent blood vessel within the ovarian stroma was observed in PCOD ovaries (Fig. 2A), whereas none or very weak color signal was demonstrated in normal cycling ovaries (Fig. 2B). However, an increased visualization rate of 83% for preovulatory follicles (one prominent blood vessel around developing follicle, 9th to 14th day) (Fig. 2C) and 100% visualization rate for corpora lutea blood vessels were observed. Depending on the size and the shape of the corpus luteum, color flow sonography showed an abundant vascular area or dense "halo" of blood vessels around the corpora lute a (Fig. 2D). No significant difference was found between the pulsed Doppler measurements of the left and right 512 Aleem and Predanic pea and color flow sonography pea Normal ovulatory cycle Days of the menstrual cycle Figure 1 Color Doppler visualization rates (%) in PCOD patients and 40 women with spontaneously cycling ovaries. uterine arteries, as well as for the lowest index values between left and right ovaries in PCOD patients, which allowed us to use the average value of these in statistical analysis. Blood flow characteristics (resistance index, pulsatility index, and peak systolic velocity) obtained from ovarian blood vessels in PCOD ovaries and control group of patients are summarized in Table 1. A significant difference was found for resistance index and pulsatility index values between PCOD ovaries and ovaries in the follicular phase (3rd to 8th day, P < 0.01). Although resistance index and pulsatility index values obtained from the corpus luteum blood vessels showed low values, especially in the late luteal phase (22nd day to the end of the cycle), a statistical significance was not achieved. However, a significant difference was noted between blood flow velocities (peak systolic velocity) in PCOD ovaries and corpora lutea (P < 0.01), indicating significantly increased blood velocities due to abundant angiogenesis within the corpus luteum. When blood flow parameters obtained from the ovarian stromal vessels in PCOD patients were correlated with ovarian morphological characteristics, no statistically significant difference was observed. The vascular impedance to blood flow was influenced neither by ovarian volume nor by the number offollicles. Furthermore, no correlation was found between serum hormone concentrations and resistance index or pulsatility index values, except for a positive correlation between LH levels and increased peak systolic velocity in ovarian vessels (P < 0.001) (Fig. 3). Additionally, a trend toward lower resistance index and pulsatility index values with an increase in LH serum levels, as well as a trend in higher T levels and, consequently, higher peak systolic velocities were observed, but in both cases a level of statistical significance was not achieved. Table 2 presents a summary of uterine artery blood flow data obtained from PCOD and control groups of patients. A higher resistance to blood flow

4 Figure 2 (A), A characteristic vascular pattern of a polycystic ovary, a prominent dilated blood vessel within the ovarian stroma (arrow). (B), Early follicular phase of the spontaneously cycling ovarian vascularity noted with color Doppler. (e), Preovulatory follicle, note a blood vessel close to the follicular wall (arrow). (D), A corpus luteum surrounded with typical vascular pattern-a dense "halo" of engorged blood vessels (arrows). Insufficient knowledge of PCOD etiology and pathophysiology makes proposed medical or surgical therapy for PCOD patients desiring fertility empirical and the subject of discussion. Regarding ultrasonic ovarian appearance, we found a large number of PCOD ovaries with smaller mean volumes and a smaller number of follicles than published in previous studies (1,11,12). However, according to a previous study, up to 30% ofpcod ovaries will have normal volume (13), whereas PCOD-like ovaries can be noted in a broad spectrum of hormonal imbalance and even in 16% of normal ovulatory women (14). We hope with the help of transvaginal color Doppler sonography, a new noninvasive modality in the assessment of organ vascularity, to shine more light on pathophysiological mechanisms of PCOD. Estradiol serum levels are considered to play an important role as moderator of uterine and ovarian vascularity (2-4). Several investigators demonstrated a correlation between serum LH rise and Aleem and Predanic was found in the control group of patients during the early follicular phase (3rd to 8th day), implicating very low E2 levels. With the rise of E2 levels in the preovulatory follicular phase (9th to 14th day) and in the luteal phase combined with an increase in P serum concentrations, a decrease in resistance index and pulsatility index values was noted. However, no significant changes in blood flow velocities during the normal spontaneous menstrual cycle was noted. No significant correlation was found between serum hormone levels and obtained uterine artery resistance index, pulsatility index, or peak systolic velocity values in PCOD patients. DISCUSSION pea and color flow sonography 513

5 Table 1 Blood Flow Parameters Found in Ovarian Vessels of PCOD and Control Groups' No. of Resistance Pulsatility Peak systolic Group patients index index velocity PCOD :t :t :t 3.2 Days 3 to 8 (0.36 to 0.71) (0.52 to 1.61) (5.5 to 26.2) Control group Days 3 to :t 0.06t 1.87 :t 0.38t 9.6 :t 2.1 (0.57 to 1.00) (0.94 to 3.92) (6.5 to 17.0) Days 9 to :t :t :t 2.9 (0.49 to 0.69) (0.73 to 1.34) (10.0 to 15.7) Days 15 to :t :t :t 3.1 t (0.50 to 0.63) (0.71 to 1.09) (8.0 to 51.0) Days 22 to :t :t :t 2.6t (0.40 to 0.54) (0.51 to 0.99) (5.4 to 48.3) * Values are means :t SEM with ranges in parentheses. t p < 0.01 compared with PCOD patients. Table 2 Blood Flow Parameters Found in Uterine Artery of PCOD and Control Groups' No. of Resistance Pulsatility Peak systolic Group patients index index velocity PCOD :t :t :t 1.5 Days 3 to 8 (0.79 to 1.00) (1.78 to 6.70) (21.1 to 58.3) Control group Days 3 to :t :t :t 2.6 (0.89 to 1.00) (2.39 to 6.25) (23.3 to 46.4) Days 9 to :t 0.04t 1.66 :t 0.53t 33.4 :t 3.8 (0.76 to 1.00) (1.66 to 5.10) (21.3 to 48.0) Days 15 to :t 0.02t 2.39 :t 0.15t 40.5 :t 2.8 (0.78 to 1.00) (1.64 to 3.53) (22.0 to 60.0) Days 22 to :t 0.02t 2.15 :t 0.16t 43.9 :t 2.9 (0.70 to 1.00) (1.34 to 4.42) (22.4 to 68.1) * Values are means :t SEM with ranges in parentheses. t p < 0.01 compared with PCOD patients. blood flow changes in intrafollicular vessels during the periovulatory period (6,7,9). Mter follicular rupture and corpus luteum development, intraovarian vascularity is transformed into a characteristic blood flow pattern called "luteal conversion." This increased turbulent flow can be explained by changes in the spiral intraovarian vessel network due to formation of arteriovenous shunts during the luteal phase (15). These specific vascular changes in spontaneously cycling ovarian changes presumably will not be observed in PCOD ovaries due to the lack of cyclic changes of hormones. However, our findings of higher visualization rates for stromal blood vessels in PCOD ovaries, when compared with ovaries in the follicular phase of the control group of patients, as well as resistance index and pulsatility index values similar to those found in corpus luteum blood vessels, indicate that stromal vessels probably are dilated and engorged in PCOD ovaries. Visualization of distinct stromal arteries in PCOD ovaries L H ze.8 10.S , zo.s Ovarian blood velocity (CIII/S) Figure 3 Scattergram of the correlation test between serum LH values and the blood velocity within the ovarian stromal vessels (Pearson correlation test). Slope = (r = ; t = ; df= 34). 514 Aleem and Predanic pea and color flow sonography as early as cycle days 3 to 8 is a first significant difference in vascular pattern from spontaneously cycling ovaries and is not correlated to cyclic serum E2 level. A significant decrease in vascular impedance to blood flow in the ovarian artery (16) and in vessels around the follicles, in correlation with an increase in the number of follicles and serum E2 concentrations (10), was observed after ovarian stimulation with gonadotropin preparations. Another study showed that PCOD patients stimulated with clomiphene citrate reveal low serum E2 levels and increased vascular impedance to blood flow in the main ovarian arteries (17). The authors suggested low serum E2 levels as responsible for impaired ovarian circulation. With respect to this data, iflow E2 levels are indeed the cause of poor ovarian vascularity in PCOD patients and consequently an inadequate response to hormonal therapy, then it would not be possible to observe higher blood vessel visualization rates in stromal ovarian vessels in our examined group ofpcod ovaries versus ovaries in early follicular phase of the control group. Furthermore, our observations of high vascular impedance of uterine arteries in PCOD patients showed similarity with blood flow parameters obtained in the early follicular phase of the normal cycle (3rd to 8th day), when low E2 levels usually are present. It appears that low E2 concentrations found in PCOD patients is the cause of high vascular impedance in uterine arteries but could not be the moderator of increased vascularity and vessel dilatation in their ovarian vessels. Therefore, it is possible that some factor other then E2 level could be the cause for increased stromal vascularity in PCOD ovaries. A linear increase in the capillary cross-sectional area of the theca interna has been observed after the LH surge in the spontaneously cycling ovaries (18). This increase in capillary area (blood flow) was attributed to vasodilatation, because there was no

6 corresponding increase in the number of blood vessels (18). Additionally, some authors reported that, at the time of the LH peak, an angiogenesis and penetration of blood vessels (with increased peak blood flow velocities) into the granulosa layer can be detected with color and pulsed Doppler (9). Our data showed a significant positive correlation between higher LH serum levels and an increase in blood flow velocities, as well as a trend toward lower resistance index and pulsatility index values with the increase of serum LH in PCOD patients. Elevated LH serum levels could be implicated as a reasonable cause of aforementioned hemodynamic changes in the stromal vessels of polycystic ovaries. However, it is likely that LH is not involved directly in vascular network hemodynamic changes but may be involved through the action of a mediator(s)-probably prostaglandins (PGs). One may speculate that PGs may playa secondary role as potent vascular vasodilatators in polycystic ovaries, which can be observed with transvaginal color Doppler sonography as an increased visualization rate of ovarian stromal blood vessels. Luteinizing hormone stimulates PG biosynthesis and steroidogenesis in preovulatory follicles before ovulation (19). A substantial increase in the production ofpge2a and PGF2a 4 to 5 hours after gonadotropin stimulation has been reported (20). It appears that PGF 2 is a stimulator of ovarian ovulation, whereas PGE 2 seems to suppress ovulation (21). Among prostaglandins, PGE2 and PGI2 are assumed to be potent vasodilatators, which markedly increase local blood flow (22), such as in corpora lutea (23), causing vascular "luteal conversion." However, a continuous infusion of LH throughout the cycle, in experimental animals, causes unbalance between PGE2 and PGF 2 levels, suppressing ovulation with an increase in ovarian blood flow (24). In another study, a significant reduction of peak systolic blood velocity within the preovulatory follicle vessels was observed (despite an adequate LH surge) after ingestion of paracetamol drug, pointing out a direct correlation between LH levels, prostaglandin activity, and blood flow changes (25). In conclusion, we found a vascular pattern for polycystic ovaries consisting of characteristic ovarian stromal vascularity with positive correlation between an increase in blood flow velocities and serum LH levels and a trend toward lower values for mean resistance index and pulsatility index values, whereas uterine arteries showed increased resistance index and pulsatility index values, possibly because oflow serum E2 levels. Therefore, we believe that assessment of ovarian and uterine vascularity may add greater understanding of the ovarian hemodynamic changes to traditional endocrinologic and ultrasonographic findings of PCOD. Such information hopefully may provide us with an answer as to why many PCOD patients are resistant to available treatment regimens. REFERENCES 1. Takahashi K, Eda Y, Okada S,Abu-MusaA, Yoshino K, Kitao M. Morphological assessment of polycystic ovary using transvaginal ultrasound. Hum Reprod 1993;8: Scholtes MCW, Wladimiroff JW, van Rijen HJM, Hop WCJ. Uterine and ovarian flow velocity waveforms in the normal menstrual cycle: a transvaginal Doppler study. Fertil Steril 1989;52: Steer CV, Campbell S, Pampiglione JS, Kingsland CR, Mason BA, Collins WP. Transvaginal colour flow imaging ofthe uterine arteries during the ovarian and menstrual cycles. Hum Reprod 1990;5: de Ziegler D, Bessis R, Frydman R. Vascular resistance of uterine arteries: physiological effects of estradiol and progesterone. Fertil Steril 1991;55: Kmjak A, Kupesic-Urek S, Schulman H, Zalud 1. Transvaginal color flow Doppler in the assessment of ovarian and uterine blood flow in infertile women. Fertil SterilI991;56: Collins W, Jurkovic D, Bourne T, Kurjak A, Cambell S. Ovarian morphology, endocrine function and intra-follicular blood flow during the peri-ovulatory period. Hum Reprod 1991; 6: Campbell S, Bourne TH, Waterstone J, Reynolds KM, Crayford TJB, Jurkovic D, et al. Transvaginal color blood flow imaging of the periovulatory follicle. Fertil Steril 1993; 60: Balakier H, Stronell RD. Color Doppler assessment offolliculogenesis in in vitro fertilization patients. Fertil Steril 1994;62: Bourne TH, Jurkovic D, Waterstone S, Campbell S, Collins WP. Intrafollicular blood flow during human ovulation. Ultrasound Obstet Gynecol 1991; 1: Weiner Z, Thaler I, Levron J, Lewit N, Itskovitz-Eldor J. Assessment of ovarian and uterine blood flow by transvaginal color Doppler in ovarian-stimulated women: correlation with the number of follicles and steroid hormone levels. Fertil Steril 1993;59: Pache TD, de Jong FH, Hop WC, Fauser BCJM. Association between ovarian changes assessed by transvaginal sonography and clinical and endocrine signs of the polycystic ovary syndrome. Fertil Steril 1993;59: Fos R, Hull M. Ultrasound diagnosis of polycystic ovaries. Ann NY Acad Sci 1993;687: Yeh HS, Futterweit W, Thornton JC. Polycystic ovarian disease: US features in 104 patients. Radiology 1987; 163: Gadir AA, Khatim MS, Mowafi RS, Alnaser HMI, Muharib NS, Shaw RW. Implications of ultrasonically diagnosed polycystic ovaries: 1. Correlations with basal hormonal levels. Hum Reprod 1992;7: Merce LT, Garces D, Barco MJ, de la Fuente F. Intraovarian Doppler velocimetry in ovulatory, dysovulatory and anovulatory cycles. Ultrasound Obstet GynecoI1992;2: Deutinger J, Reinthaller A, Bernaschek G. Transvaginal pulsed Doppler measurement of blood flow velocity in the ovarian arteries during cycle stimulation and after follicle puncture. Fertil Steril1989;51: Schurz B, Schon HJ, Wenzl R, Wolfgang E, Huber J, Reinold Aleem and Predanic pea and color flow sonography 515

7 E. Endovaginal Doppler flow measurement of the ovarian artery in patients with a normal menstrual cycle and with polycystic ovary syndrome during in vitro fertilization. J Clin Ultrasound 1993;21: Cavander JL, Murdoch WJ. Morphological studies ofthe microcirculatory system of peri ovulatory ovine follicles. BioI Reprod 1990;42: Larson L, Olafsson J, Hellberg 0, Brannstrom M, Selstam G, Hedin L. Regulation of prostaglandin biosynthesis by luteinizing hormone and bradykinin in rat preovulatory follicles in vitro. Prostaglandins 1991;41: Le Maire WJ, Yang NST, Behrman HH, Marsh JM. Preovulatory changes in the concentration of prostaglandins in rabbit graafian follicles. Prostaglandins 1973;3: Richman KA, Wright KH, Wallach EE. Local ovarian effects of prostaglandin E2 and F2 on human chorionic gonadotro- pin-induced ovulation in the rabbit. Obstet GynecoI1974;43: Raud J. Vasodilatation and inhibition of mediator release represent two distinct mechanisms of prostaglandin modulation of acute mast cell-dependent inflammation. Br J PharmacoI1990;99: Alila HW, Corradino RA, Hansel W. A comparison of the effects of cyclooxygenase prostanoids on progesterone production by small and large bovine luteal cells. Prostaglandins 1988; 36: Brannian JD, Terranova PF. Involvement of prostaglandins in LH-induced superovulation in the cyclic hamster. Prostaglandins 1991;41: Bourne TH, Reynolds K, Waterstone J, Okokon E, Jurkovic D, Campbell S, et al. Paracetamol-associated luteinized unruptured follicle syndrome:effect on intrafollicular blood flow. Ultrasound Obstet Gynecol 1991; 1: Aleem and Predanic pea and color flow sonography j I I j

Endometrial blood flow response to hormone replacement therapy in women with premature ovarian failure: a transvaginal Doppler study

Endometrial blood flow response to hormone replacement therapy in women with premature ovarian failure: a transvaginal Doppler study . M.,nopause FERTILITY AND STERILITY Vol. 63, No.3, March 1995 Copyright 1995 American Society for Reproductive Medicine Printed on acid-free paper in U. s. A. Endometrial blood flow response to hormone

More information

Modifications in uterine and intraovarian artery impedance in cycles of treatment with exogenous gonadotropins: effects of luteal phase support

Modifications in uterine and intraovarian artery impedance in cycles of treatment with exogenous gonadotropins: effects of luteal phase support FERTILITY AND STERILITY Vol. 64, No.1, July 1995 Copyright 1995 American Society for Reproductive Medicine Printed on acid-free paper in U. S. A. Modifications in uterine and intraovarian artery impedance

More information

Utility of color Doppler indices of dominant follicular

Utility of color Doppler indices of dominant follicular Ultrasound Obstet Gynecol 2002; 20: 592 596 Utility of color Doppler indices of dominant follicular Blackwell Science, Ltd blood flow for prediction of clinical factors in in vitro fertilization-embryo

More information

The relationship between ovarian vascularity and the duration of stimulation in in-vitro fertilization

The relationship between ovarian vascularity and the duration of stimulation in in-vitro fertilization Human Reproduction vol.12 no.6 pp.1240 1245, 1997 The relationship between ovarian vascularity and the duration of stimulation in in-vitro fertilization S.Bassil 1, C.Wyns, D.Toussaint-Demylle, M.Nisolle,

More information

CASE 41. What is the pathophysiologic cause of her amenorrhea? Which cells in the ovary secrete estrogen?

CASE 41. What is the pathophysiologic cause of her amenorrhea? Which cells in the ovary secrete estrogen? CASE 41 A 19-year-old woman presents to her gynecologist with complaints of not having had a period for 6 months. She reports having normal periods since menarche at age 12. She denies sexual activity,

More information

Ultrasonographic patterns of polycystic ovaries: color Doppler and hormonal correlations

Ultrasonographic patterns of polycystic ovaries: color Doppler and hormonal correlations Ultrasound Obstet Gynecol 1998;11:332 336 Ultrasonographic patterns of polycystic ovaries: color Doppler and hormonal correlations C. Battaglia, P. G. Artini, M. Salvatori, S. Giulini, F. Petraglia, N.

More information

Neil Goodman, MD, FACE

Neil Goodman, MD, FACE Initial Workup of Infertile Couple: Female Neil Goodman, MD, FACE Professor of Medicine Voluntary Faculty University of Miami Miller School of Medicine Scope of Infertility in the United States Affects

More information

LUTEINIZED UNRUPTURED FOLLICLE SYNDROME: A SUBTLE CAUSE OF INFERTILITY*

LUTEINIZED UNRUPTURED FOLLICLE SYNDROME: A SUBTLE CAUSE OF INFERTILITY* FERTILITY AND STERILITY Copyright c 1978 The American Fertility Society Vol. 29, No.3, March 1978 Printed in U.S.A. LUTEINIZED UNRUPTURED FOLLICLE SYNDROME: A SUBTLE CAUSE OF INFERTILITY* JAROSLA V MARIK,

More information

The reproductive lifespan

The reproductive lifespan The reproductive lifespan Reproductive potential Ovarian cycles Pregnancy Lactation Male Female Puberty Menopause Age Menstruation is an external indicator of ovarian events controlled by the hypothalamicpituitary

More information

International Journal of Current Research and Academic Review

International Journal of Current Research and Academic Review International Journal of Current Research and Academic Review ISSN: 2347-3215 (Online) Volume 6 Journal homepage: http://www.ijcrar.com Number 5 (May-2018) doi: https://doi.org/10.20546/ijcrar.2018.605.002

More information

clinical outcome and hormone profiles before and after laparoscopic electroincision of the ovaries in women with polycystic ovary syndrome

clinical outcome and hormone profiles before and after laparoscopic electroincision of the ovaries in women with polycystic ovary syndrome & clinical outcome and hormone profiles before and after laparoscopic electroincision of the ovaries in women with polycystic ovary syndrome Zulfo Godinjak¹*, Ranka Javorić² 1 Gynecology and Obstetrics

More information

Original Research Article

Original Research Article Original Research Article Polycystic Ovarian Syndrome: A Hormonal and Radiological Correlation Haque Riyajul Aqbalul Nazma Begum 1, K Ashoka Reddy 2, Md. Kaleemullah 3 1 Final Year Post Graduate, 2 Senior

More information

Daily blood hormone levels related to the luteinizing hormone surge in anovulatory cycles

Daily blood hormone levels related to the luteinizing hormone surge in anovulatory cycles FRTILITY AND STRILITY Copyright 1983 The American Fertility Society Printed in U.8A. Daily blood hormone levels related to the luteinizing hormone surge in anovulatory cycles Chung H. Wu, M.D. * F. Susan

More information

Ebtisam S. S. Al-Mizyen, M.B. Ch.B., M. Phil. * Jurgis G. Grudzinskas, M.D., F.R.C.O.G., F.R.A.C.O.G., B.Sc., M.B., B.S.

Ebtisam S. S. Al-Mizyen, M.B. Ch.B., M. Phil. * Jurgis G. Grudzinskas, M.D., F.R.C.O.G., F.R.A.C.O.G., B.Sc., M.B., B.S. Middle East Fertility Society Journal Vol. 12, No. 3, 27 Copyright Middle East Fertility Society Ultrasonographic observations following unilateral and bilateral laparoscopic ovarian diathermy in infertile

More information

Effect of the Dominant Follicle Aspiration before or after Luteinizing Hormone Surge on the Corpus Luteum Formation in the Cow

Effect of the Dominant Follicle Aspiration before or after Luteinizing Hormone Surge on the Corpus Luteum Formation in the Cow Journal of Reproduction and Development, Vol. 52, No. 1, 2006 Research Note Effect of the Dominant Follicle Aspiration before or after Luteinizing Hormone Surge on the Corpus Luteum Formation in the Cow

More information

Investigation: The Human Menstrual Cycle Research Question: How do hormones control the menstrual cycle?

Investigation: The Human Menstrual Cycle Research Question: How do hormones control the menstrual cycle? Investigation: The Human Menstrual Cycle Research Question: How do hormones control the menstrual cycle? Introduction: The menstrual cycle (changes within the uterus) is an approximately 28-day cycle that

More information

Chapter 27 The Reproductive System. MDufilho

Chapter 27 The Reproductive System. MDufilho Chapter 27 The Reproductive System 1 Figure 27.19 Events of oogenesis. Before birth Meiotic events 2n Oogonium (stem cell) Mitosis Follicle development in ovary Follicle cells Oocyte 2n Primary oocyte

More information

Achieving Pregnancy: Obesity and Infertility. Jordan Vaughan, MSN, APN, WHNP-BC Women s Health Nurse Practitioner Nashville Fertility Center

Achieving Pregnancy: Obesity and Infertility. Jordan Vaughan, MSN, APN, WHNP-BC Women s Health Nurse Practitioner Nashville Fertility Center Achieving Pregnancy: Obesity and Infertility Jordan Vaughan, MSN, APN, WHNP-BC Women s Health Nurse Practitioner Nashville Fertility Center Disclosures Speakers Bureau EMD Serono Board of Directors Nurse

More information

Endocrinology of the Female Reproductive Axis

Endocrinology of the Female Reproductive Axis Endocrinology of the Female Reproductive Axis girlontheriver.com Geralyn Lambert-Messerlian, PhD, FACB Professor Women and Infants Hospital Alpert Medical School at Brown University Women & Infants BROWN

More information

JSAR Young Investigator Award. Studies of Follicular Vascularity Associated with Follicle Selection and Ovulation in Cattle

JSAR Young Investigator Award. Studies of Follicular Vascularity Associated with Follicle Selection and Ovulation in Cattle Journal of Reproduction and Development, Vol. 53, No. 1, 2007 JSAR Young Investigator Award Studies of Follicular Vascularity Associated with Follicle Selection and Ovulation in Cattle Tomas J. ACOSTA

More information

Embryology Lecture # 4

Embryology Lecture # 4 1 Quick Review: Oogenesis : - Oogonia start appear in the ovary when the age of the fetus 1 is th (5 week). - Then the Oogonia transformed into 1ry Oocyte. - 1ry Oocyte is surrounded by a follicle (cover).

More information

me LUTEINIZED UNRUPTURED FOLLICLE SYNDROME AND ENDOMETRIOSIS

me LUTEINIZED UNRUPTURED FOLLICLE SYNDROME AND ENDOMETRIOSIS FERTILITY AND STERILITY Copyright c 980 The American Fertility Society Vol. 33,, JanuaEY 980 Printed in U.S.A. me LUTEINIZED UNRUPTURED FOLLICLE SYNDROME AND ENDOMETRIOSIS W. PAULDMOWSKI, M.D.,.PH.D.*

More information

Department of Obstetrics and Gynecology, The University of Texas Health Science Center at San Antonio, San Antonio, Texas

Department of Obstetrics and Gynecology, The University of Texas Health Science Center at San Antonio, San Antonio, Texas FERTILITY AND STERILITY Copyright 1991 The American Fertility Society Vol. 56, No. 2, August 1991 Printed on ocid-free paper in U.S.A. Follicular size at the time of human chorionic gonadotropin administration

More information

Page 1. A wide variety of ovarian abnormalities are encountered in clinical practice

Page 1. A wide variety of ovarian abnormalities are encountered in clinical practice A wide variety of ovarian abnormalities are encountered in clinical practice Common Problems Anovulatory follicles Persistent anovulatory follicles Hemorrhagic/Luteinized follicles Persistent corpus luteum

More information

Polycystic ovary syndrome: it is always bilateral?

Polycystic ovary syndrome: it is always bilateral? Ultrasound Obstet Gynecol 1999;14:183 187 Polycystic ovary syndrome: it is always bilateral? C. Battaglia, G. Regnani, F. Petraglia*, M. R. Primavera, M. Salvatori and A. Volpe Department of Obstetrics

More information

1. During the follicular phase of the ovarian cycle, the hypothalamus releases GnRH.

1. During the follicular phase of the ovarian cycle, the hypothalamus releases GnRH. 1. During the follicular phase of the ovarian cycle, the hypothalamus releases GnRH. 2. This causes the anterior pituitary to secrete small quantities of FSH and LH. 3. At this time, the follicles in the

More information

Reproductive Health and Pituitary Disease

Reproductive Health and Pituitary Disease Reproductive Health and Pituitary Disease Janet F. McLaren, MD Assistant Professor Division of Reproductive Endocrinology and Infertility Department of Obstetrics and Gynecology jmclaren@uabmc.edu Objectives

More information

Doppler flow velocities of uterine and ovarian arteries & hormonal patterns in patients with Polycystic Ovary Syndrome (PCOS)

Doppler flow velocities of uterine and ovarian arteries & hormonal patterns in patients with Polycystic Ovary Syndrome (PCOS) Original article: Doppler flow velocities of uterine and ovarian arteries & hormonal patterns in patients with Polycystic Ovary Syndrome (PCOS) Dr. Deepali Dhingra*#, Dr. Shashi Prateek*, Dr. Renuka Sinha*,

More information

Nazanin Farshchian, Siavash Teimuri Nezhad, and Parisa Bahrami Kamangar RESEARCH ABSTRACT. What this study adds: Background

Nazanin Farshchian, Siavash Teimuri Nezhad, and Parisa Bahrami Kamangar RESEARCH ABSTRACT. What this study adds: Background The combination of letrozole and metformin has a better therapeutic effect on uterine and ovarian arteries in PCOS patients than the combination of clomiphene citrate and metformin Nazanin Farshchian,

More information

Blood Flow in Functional Cysts and Benign Ovarian Neoplasms in Premenopausal Women

Blood Flow in Functional Cysts and Benign Ovarian Neoplasms in Premenopausal Women Blood Flow in Functional Cysts and Benign Ovarian Neoplasms in Premenopausal Women Juan Luis Alcazar, MD, Tania Errasti, MD, Matias Jurado, MD To assess the value of transvaginal calor Doppler sonography

More information

The antiandrogenic effect of flutamide improves uterine perfusion in women with polycystic ovary syndrome

The antiandrogenic effect of flutamide improves uterine perfusion in women with polycystic ovary syndrome FERTILITY AND STERILITY VOL. 77, NO. 6, JUNE 2002 Copyright 2002 American Society for Reproductive Medicine Published by Elsevier Science Inc. Printed on acid-free paper in U.S.A. The antiandrogenic effect

More information

Reproductive FSH. Analyte Information

Reproductive FSH. Analyte Information Reproductive FSH Analyte Information 1 Follicle-stimulating hormone Introduction Follicle-stimulating hormone (FSH, also known as follitropin) is a glycoprotein hormone secreted by the anterior pituitary

More information

Treatment 3 Days After Ovulation In Mares

Treatment 3 Days After Ovulation In Mares Luteal Regression And Follicle Development Following Prostaglandin-F 2α Treatment 3 Days After Ovulation In Mares D.R. Bergfelt a, R.A. Pierson b, and O.J. Ginther a a University of Wisconsin, Madison,

More information

Approach to ovulation induction and superovulation in women with a history of infertility. Anatte E. Karmon, MD

Approach to ovulation induction and superovulation in women with a history of infertility. Anatte E. Karmon, MD Approach to ovulation induction and superovulation in women with a history of infertility Anatte E. Karmon, MD Disclosures- Anatte Karmon, MD No financial relationships to disclose 2 Objectives At the

More information

Stage 4 - Ovarian Cancer Symptoms

Stage 4 - Ovarian Cancer Symptoms WELCOME Stage 4 - Ovarian Cancer Symptoms University of Baghdad College of Nursing Department of Basic Medical Sciences Overview of Anatomy and Physioloy II Second Year Students Asaad Ismail Ahmad,

More information

Polycystic Ovarian Syndrome (PCOS) LOGO

Polycystic Ovarian Syndrome (PCOS) LOGO Polycystic Ovarian Syndrome (PCOS) Ma qianhong Ob/Gyn Department LOGO Contents Epidemiology and Definition Pathophysiology, Endocrinological Features Diagnostic Criteria Treatment Prognosis Introduction

More information

Female Reproductive Physiology. Dr Raelia Lew CREI, FRANZCOG, PhD, MMed, MBBS Fertility Specialist, Melbourne IVF

Female Reproductive Physiology. Dr Raelia Lew CREI, FRANZCOG, PhD, MMed, MBBS Fertility Specialist, Melbourne IVF Female Reproductive Physiology Dr Raelia Lew CREI, FRANZCOG, PhD, MMed, MBBS Fertility Specialist, Melbourne IVF REFERENCE Lew, R, Natural History of ovarian function including assessment of ovarian reserve

More information

ROLE OF HORMONAL ASSAY IN DIAGNOSING PCOD DR GAANA SREENIVAS (JSS,MYSURU)

ROLE OF HORMONAL ASSAY IN DIAGNOSING PCOD DR GAANA SREENIVAS (JSS,MYSURU) ROLE OF HORMONAL ASSAY IN DIAGNOSING PCOD DR GAANA SREENIVAS (JSS,MYSURU) In 1935, Stein and Leventhal described 7 women with bilateral enlarged PCO, amenorrhea or irregular menses, infertility and masculinizing

More information

Female Reproductive System. Lesson 10

Female Reproductive System. Lesson 10 Female Reproductive System Lesson 10 Learning Goals 1. What are the five hormones involved in the female reproductive system? 2. Understand the four phases of the menstrual cycle. Human Reproductive System

More information

THE MENSTRUAL CYCLE INA S. IRABON, MD, FPOGS, FPSRM, FPSGE OBSTETRICS AND GYNECOLOGY REPRODUCTIVE ENDOCRINOLOGY AND INFERTILITY

THE MENSTRUAL CYCLE INA S. IRABON, MD, FPOGS, FPSRM, FPSGE OBSTETRICS AND GYNECOLOGY REPRODUCTIVE ENDOCRINOLOGY AND INFERTILITY THE MENSTRUAL CYCLE INA S. IRABON, MD, FPOGS, FPSRM, FPSGE OBSTETRICS AND GYNECOLOGY REPRODUCTIVE ENDOCRINOLOGY AND INFERTILITY REFERENCE Comprehensive Gynecology 7 th edition, 2017 (Lobo RA, Gershenson

More information

Hormonal Control of Human Reproduction

Hormonal Control of Human Reproduction Hormonal Control of Human Reproduction Bởi: OpenStaxCollege The human male and female reproductive cycles are controlled by the interaction of hormones from the hypothalamus and anterior pituitary with

More information

N. Shirazian, MD. Endocrinologist

N. Shirazian, MD. Endocrinologist N. Shirazian, MD Internist, Endocrinologist Inside the ovary Day 15-28: empty pyfollicle turns into corpus luteum (yellow body) Immature eggs Day 1-13: 13: egg developing inside the growing follicle Day

More information

Milan Reljič, Ph.D., Veljko Vlaisavljević, Ph.D., Vida Gavrić, M.Sc., Borut Kovačič, Ph.D.,

Milan Reljič, Ph.D., Veljko Vlaisavljević, Ph.D., Vida Gavrić, M.Sc., Borut Kovačič, Ph.D., FERTILITY AND STERILITY VOL. 75, NO. 3, MARCH 2001 Copyright 2001 American Society for Reproductive Medicine Published by Elsevier Science Inc. Printed on acid-free paper in U.S.A. Value of the serum estradiol

More information

Two important cells in female are the theca cells and the granulose cells. Granulosa cells are affected by the two gonadotropin hormones; FSH and LH.

Two important cells in female are the theca cells and the granulose cells. Granulosa cells are affected by the two gonadotropin hormones; FSH and LH. 1 UGS physiology sheet #13 lecture 3 Dr.Saleem Khresha. Now we will start discussing the female reproductive system Ovarian Steroids Two important cells in female are the theca cells and the granulose

More information

Effect of troglitazone on endocrine and ovulatory performance in women with insulin resistance related polycystic ovary syndrome

Effect of troglitazone on endocrine and ovulatory performance in women with insulin resistance related polycystic ovary syndrome FERTILITY AND STERILITY VOL. 71, NO. 2, FEBRUARY 1999 Copyright 1999 American Society for Reproductive Medicine Published by Elsevier Science Inc. Printed on acid-free paper in U.S.A. Effect of troglitazone

More information

Infertility: failure to conceive within one year of unprotected regular sexual intercourse. Primary secondary

Infertility: failure to conceive within one year of unprotected regular sexual intercourse. Primary secondary Subfertility Infertility: failure to conceive within one year of unprotected regular sexual intercourse. Primary secondary Infertility affects about 15 % of couples. age of the female. Other factors that

More information

Prevalence of Anovulation in Subfertile Women in Kerbala 2012, A descriptive Cross-Sectional Study

Prevalence of Anovulation in Subfertile Women in Kerbala 2012, A descriptive Cross-Sectional Study Prevalence of Anovulation in Subfertile Women in Kerbala 2012, A descriptive Cross-Sectional Study Mousa Mohsen Ali* Wasan Ghazi* HayderAamerAbboud^ *Kerbala University, College of Medicine, Gynecology

More information

Infertility for the Primary Care Provider

Infertility for the Primary Care Provider Infertility for the Primary Care Provider David A. Forstein, DO FACOOG Clinical Associate Professor Obstetrics and Gynecology University of South Carolina School of Medicine Greenville Disclosure I have

More information

Endocrine control of female reproductive function

Endocrine control of female reproductive function Medicine School of Women s & Children s Health Discipline of Obstetrics & Gynaecology Endocrine control of female reproductive function Kirsty Walters, PhD Fertility Research Centre, School of Women s

More information

Luteal phase rescue after GnRHa triggering Progesterone and Estradiol

Luteal phase rescue after GnRHa triggering Progesterone and Estradiol Luteal phase rescue after GnRHa triggering Progesterone and Estradiol L. Engmann University of Connecticut Disclaimer Fertility Speaker Bureau Merck Pharmaceuticals Introduction GnRH agonist is effective

More information

REPRODUCTIVE ENDOCRINOLOGY

REPRODUCTIVE ENDOCRINOLOGY FERTILITY AND STERILITY VOL. 76, NO. 5, NOVEMBER 2001 Copyright 2001 American Society for Reproductive Medicine Published by Elsevier Science Inc. Printed on acid-free paper in U.S.A. REPRODUCTIVE ENDOCRINOLOGY

More information

Reproductive Endocrinology. Isabel Hwang Department of Physiology Faculty of Medicine University of Hong Kong Hong Kong May2007

Reproductive Endocrinology. Isabel Hwang Department of Physiology Faculty of Medicine University of Hong Kong Hong Kong May2007 Reproductive Endocrinology Isabel Hwang Department of Physiology Faculty of Medicine University of Hong Kong Hong Kong May2007 isabelss@hkucc.hku.hk A 3-hormone chain of command controls reproduction with

More information

OVARY The surface of the ovary is covered with surface epithelium

OVARY The surface of the ovary is covered with surface epithelium OVARY Cow The ovary, or female gonad, is: 1. an exocrine gland, producing oocytes 2. an endocrine gland, secreting hormones, i.e., estrogen and progesterone OVARY OVARY The surface of the ovary is covered

More information

Reproduction and Development. Female Reproductive System

Reproduction and Development. Female Reproductive System Reproduction and Development Female Reproductive System Outcomes 5. Identify the structures in the human female reproductive system and describe their functions. Ovaries, Fallopian tubes, Uterus, Endometrium,

More information

Ultrasound of Uterus and Ovary

Ultrasound of Uterus and Ovary 1 of 16 5/3/2005 8:34 PM Contents: Ultrasound of Uterus and Ovary Introduction Section 1: The Normal Ovary by Ultrasound Section 2: Ultrasound of Normal Ovarian Follicular Cycles Section 3: Ultrasound

More information

Superovulation of Beef Heifers with Follicle Stimulating Hormone or Human Menopausal Gonadotropin: Acute Effects on Hormone Secretion

Superovulation of Beef Heifers with Follicle Stimulating Hormone or Human Menopausal Gonadotropin: Acute Effects on Hormone Secretion Beef Research Report, 1996 Animal Science Research Reports 1997 Superovulation of Beef Heifers with Follicle Stimulating Hormone or Human Menopausal Gonadotropin: Acute Effects on Hormone Secretion Acacia

More information

Gonadotrophin treatment in patients with Polycystic Ovary Syndrome

Gonadotrophin treatment in patients with Polycystic Ovary Syndrome Int. J. Adv. Res. Biol. Sci. (218). 5(4): 95-99 International Journal of Advanced Research in Biological Sciences ISSN: 2348-869 www.ijarbs.com DOI: 1.22192/ijarbs Coden: IJARQG(USA) Volume 5, Issue 4-218

More information

Superovulation of Beef Heifers with Follicle Stimulating Hormone or Human Menopausal Gonadotropin: Acute Effects on Hormone Secretion

Superovulation of Beef Heifers with Follicle Stimulating Hormone or Human Menopausal Gonadotropin: Acute Effects on Hormone Secretion Superovulation of Beef Heifers with Follicle Stimulating Hormone or Human Menopausal Gonadotropin: Acute Effects on Hormone Secretion A.S. Leaflet R1362 Acacia A. Alcivar, graduate research assistant,

More information

ABSTRACT. Key words: ovulation, ovary, human, follicle, collagen, MMP and TIMP. ISBN-10: ISBN-13:

ABSTRACT. Key words: ovulation, ovary, human, follicle, collagen, MMP and TIMP. ISBN-10: ISBN-13: HUMAN OVULATION Studies on collagens, gelatinases and tissue inhibitors of metalloproteinases Anna Karin Lind Department of Obstetrics and Gynecology Institute of Clinical Sciences Sahlgrenska University

More information

Prostaglandins and follicular functions

Prostaglandins and follicular functions Prostaglandins and follicular functions David T. Armstrong M.R.C. Group in Reproductive Biology, Departments of Obstetrics & Gynaecology and Physiology, University of Western Ontario, London, Canada N6A

More information

Prediction of ovulation with the use of oral and vaginal electrical measurements during treatment with clomiphene citrate*

Prediction of ovulation with the use of oral and vaginal electrical measurements during treatment with clomiphene citrate* FERTILITY AND STERILITY Copyright 1987 The American Fertility Society Printed in U.8A. Prediction of ovulation with the use of oral and vaginal electrical measurements during treatment with clomiphene

More information

Ovulation after intravenous and intramuscular human chorionic gonadotropin*t

Ovulation after intravenous and intramuscular human chorionic gonadotropin*t FERTILITY AND STERILITY Copyright 1993 The American Fertility Society Printed on acid-free paper in U. S. A. Ovulation after intravenous and intramuscular human chorionic gonadotropin*t Robin A. Fischer,

More information

Uterus & Ovary 2015; 2: e904. doi: /uo.904; 2015 by Ahmed M Maged, et al.

Uterus & Ovary 2015; 2: e904. doi: /uo.904; 2015 by Ahmed M Maged, et al. RESEARCH ARTICLE Phytoestrogens as an alternative to estradiol in reversing the antiestrogenic effect of clomid on endometrium in ovulation induction in cases of polycystic ovarian syndrome (PCOS) Ahmed

More information

Overview of Reproductive Endocrinology

Overview of Reproductive Endocrinology Overview of Reproductive Endocrinology I have no conflicts of interest to report. Maria Yialamas, MD Female Hypothalamic--Gonadal Axis 15 4 Hormone Secretion in the Normal Menstrual Cycle LH FSH E2, Progesterone,

More information

Reproductive System. Testes. Accessory reproductive organs. gametogenesis hormones. Reproductive tract & Glands

Reproductive System. Testes. Accessory reproductive organs. gametogenesis hormones. Reproductive tract & Glands Reproductive System Testes gametogenesis hormones Accessory reproductive organs Reproductive tract & Glands transport gametes provide nourishment for gametes Hormonal regulation in men Hypothalamus - puberty

More information

Nature and Science 2017;15(8)

Nature and Science 2017;15(8) Prognostic Value of Day 3 Luteinising Hormone (LH) in the prediction of Ovarian Response in Patients with Polycystic Ovary syndrome Mohammed Samir Fouad 1 ; Mohammed Said El-Shorbagy 2, Mohammed Mohammed

More information

Serum Vascular Endothelial Growth Factor in Polycystic Ovary Syndrome and its Relation to Ovarian Drilling

Serum Vascular Endothelial Growth Factor in Polycystic Ovary Syndrome and its Relation to Ovarian Drilling Available online on www.ijtpr.com International Journal of Toxicological and Pharmacological Research 2014; 6(4): 123-127 Research Article ISSN: 0975-5160 Serum Vascular Endothelial Growth Factor in Polycystic

More information

Nitasha Garg 1 Harkiran Kaur Khaira. About the Author

Nitasha Garg 1 Harkiran Kaur Khaira. About the Author https://doi.org/10.1007/s13224-017-1082-4 ORIGINAL ARTICLE A Comparative Study on Quantitative Assessment of Blood Flow and Vascularization in Polycystic Ovary Syndrome Patients and Normal Women Using

More information

Reproductive cyclicity 19. Introduction. Page 1. repro and its story lines. Male repro: a simpler way of control

Reproductive cyclicity 19. Introduction. Page 1. repro and its story lines. Male repro: a simpler way of control Reproductive cyclicity 19 Male repro: a simpler way of control Menstrual cycles: ovary / uterine anatomy and cell types, follicular phase, ovulation, luteal phase, cyclicity Race events: removal of P4

More information

Objective: To study the role of sildenafil on the echogenic pattern of endometrium in infertile patients with bad endometrium.

Objective: To study the role of sildenafil on the echogenic pattern of endometrium in infertile patients with bad endometrium. The effect of Sildenafil on endometrial characters in patients with infertility Ali F. Al-Assadi, F.I.C.O.G.,C.A.B.O.G.1. Sajeda A. Al-Rubaye, F.I.C.O.G.1 Zainab Laaiby, M.B.Ch.B.2 (1- Assist. Prof./Basra

More information

Polycystic Ovary Syndrome HEATHER BURKS, MD OU PHYSICIANS REPRODUCTIVE MEDICINE SEPTEMBER 21, 2018

Polycystic Ovary Syndrome HEATHER BURKS, MD OU PHYSICIANS REPRODUCTIVE MEDICINE SEPTEMBER 21, 2018 Polycystic Ovary Syndrome HEATHER BURKS, MD OU PHYSICIANS REPRODUCTIVE MEDICINE SEPTEMBER 21, 2018 Learning Objectives At the conclusion of this lecture, learners should: 1) Know the various diagnostic

More information

Female Reproductive System. Justin D. Vidal

Female Reproductive System. Justin D. Vidal Female Reproductive System Justin D. Vidal If you cannot identify the tissue, then it is probably part of the female reproductive system! Introduction The female reproductive system is constantly changing,

More information

Journal of American Science 2013;9(12)

Journal of American Science 2013;9(12) Early Clomiphene Citrate for Induction of Ovulation in Women with Polycystic Ovary Syndrome a randomized controlled trial Elguindy A. 1, Hussein M. 1 * and El-Shamy R 2 1 Department of Obstetrics and Gynecology,

More information

lbt lab tests t Conrolled Ovarian Hyperstimulation Dr Soheila Ansaripour

lbt lab tests t Conrolled Ovarian Hyperstimulation Dr Soheila Ansaripour lbt lab tests t and Conrolled Ovarian Hyperstimulation Dr Soheila Ansaripour Research Instituteof Avicenna 4/23/2012 Why good prediction of poor response good prediction i of OHSS application appropriate

More information

Assisted Reproduction. Rajeevi Madankumar, 1,2 James Tsang, 1 Martin L. Lesser, 1 Daniel Kenigsberg, 1 and Steven Brenner 1 INTRODUCTION

Assisted Reproduction. Rajeevi Madankumar, 1,2 James Tsang, 1 Martin L. Lesser, 1 Daniel Kenigsberg, 1 and Steven Brenner 1 INTRODUCTION ( C 2005) DOI: 10.1007/s10815-005-4912-8 Assisted Reproduction Clomiphene citrate induced ovulation and intrauterine insemination: effect of timing of human chorionic gonadotropin injection in relation

More information

THE LUTEAL PHASE DEFECT

THE LUTEAL PHASE DEFECT FERTILITY AND STERILITY Copyright 1976 The American Fertility Society Vol. 27, No.4, April 1976 Printed in U.SA. THE LUTEAL PHASE DEFECT GEORGEANNA SEEGAR JONES, M.D. Department of Gynecology and Obstetrics,

More information

Clinical Application of Ultrasound in Infertility: From Two-dimensional to Three-dimensional

Clinical Application of Ultrasound in Infertility: From Two-dimensional to Three-dimensional R E V I E W A R T I C L E Clinical Application of Ultrasound in Infertility: From Two-dimensional to Three-dimensional Chun-Kai Chen*, Hsien-Ming Wu, Yung-Kuei Soong Transvaginal probes have enhanced sonographic

More information

Intercycle variability of day 3 follicle-stimulating hormone levels and its effect on stimulation quality in in vitro fertilization*

Intercycle variability of day 3 follicle-stimulating hormone levels and its effect on stimulation quality in in vitro fertilization* FERTILITY AND STERILITY Copyright C> 1990 The American Fertility Society Printed on acid-free paper in U.S.A. Inter variability of day 3 follicle-stimulating hormone levels and its effect on stimulation

More information

Intratumoral Blood Flow Analysis in Ovarian Cancer:

Intratumoral Blood Flow Analysis in Ovarian Cancer: Intratumoral Blood Flow Analysis in Ovarian Cancer: What Does It Mean? Kohkichi Hata, MD, PhD, Toshiyuki Hata, MD, PhD The objective of this study is to evaluate the significance of intratumoral blood

More information

Circulatory System MARE HEIFER. aorta cvc. iia eia ipa. aorta. dca. (uov) oa. uboa. uma. ubva va. bua. iia. uma. ubva. eia. ua bua. cvc.

Circulatory System MARE HEIFER. aorta cvc. iia eia ipa. aorta. dca. (uov) oa. uboa. uma. ubva va. bua. iia. uma. ubva. eia. ua bua. cvc. Circulatory System 13 MARE aorta cvc ov (uov) oa dca uboa iia eia ipa ua uma bua ubva va HEIFER iia aorta cvc eia oa uma ua bua ubva va ov (uov) uboa 18 Chapter 1 Hemodynamics Plug flow Natural disturbed

More information

Available online at Theriogenology xxx (2009) xxx xxx

Available online at   Theriogenology xxx (2009) xxx xxx Available online at www.sciencedirect.com 1 2 3 4 5 6 7 8 9 10 11 The effect of hormone treatments (hcg and cloprostenol) and season on the incidence of hemorrhagic anovulatory follicles in the mare: A

More information

Imaging in Pediatric and Adolescent Gynecology

Imaging in Pediatric and Adolescent Gynecology Background and Tools Sultan C (ed): Pediatric and Adolescent Gynecology. Evidence-Based Clinical Practice. Endocr Dev. Basel, Karger, 2004, vol 7, pp 9 22 Imaging in Pediatric and Adolescent Gynecology

More information

Reproductive Hormones

Reproductive Hormones Reproductive Hormones Male gonads: testes produce male sex cells! sperm Female gonads: ovaries produce female sex cells! ovum The union of male and female sex cells during fertilization produces a zygote

More information

The menstrual cycle. François Pralong

The menstrual cycle. François Pralong The menstrual cycle François Pralong Services d Endocrinologie, Diabétologie et Métabolisme, Hôpitaux Universitaires de Genève et Lausanne Centre des Maladies CardioVasculaires et Métaboliques, Lausanne

More information

The menstrual Cycle. François Pralong

The menstrual Cycle. François Pralong The menstrual Cycle François Pralong Services d Endocrinologie, Diabétologie et Métabolisme, Hôpitaux Universitaires de Genève et Lausanne Centre des Maladies CardioVasculaires et Métaboliques, Lausanne

More information

Superovulation with human menopausal gonadotropins is associated with endometrial gland-stroma dyssynchrony*

Superovulation with human menopausal gonadotropins is associated with endometrial gland-stroma dyssynchrony* aes FERTILITY AND STERILITY Vol. 61, No.4, April 1994 Copyright ee) 1994 The American Fertility Society Printed on acid-free paper in U. S. A. r I Superovulation with human menopausal gonadotropins is

More information

Luteal phase dysfunction in endometriosis: elevated progesterone levels in peripheral and ovarian veins during the follicular phase*

Luteal phase dysfunction in endometriosis: elevated progesterone levels in peripheral and ovarian veins during the follicular phase* FERTILITY AND STERILITY Copyrightc 1987 The American Fertility Society Printed in U.BA. Luteal phase dysfunction in endometriosis: elevated progesterone levels in peripheral and ovarian veins during the

More information

OVULATION INDUCTION. Ori Nevo, M.D., a Talia Eldar-Geva, M.D., Ph.D., b Shahar Kol, M.D., a and Joseph Itskovitz-Eldor, M.D., D.Sc.

OVULATION INDUCTION. Ori Nevo, M.D., a Talia Eldar-Geva, M.D., Ph.D., b Shahar Kol, M.D., a and Joseph Itskovitz-Eldor, M.D., D.Sc. FERTILITY AND STERILITY VOL. 79, NO. 5, MAY 2003 Copyright 2003 American Society for Reproductive Medicine Published by Elsevier Inc. Printed on acid-free paper in U.S.A. OVULATION INDUCTION Lower levels

More information

Vaginal micronized progesterone versus intramuscular progesterone for luteal support in women undergoing in vitro fertilization embryo transfer

Vaginal micronized progesterone versus intramuscular progesterone for luteal support in women undergoing in vitro fertilization embryo transfer Vaginal micronized progesterone versus intramuscular progesterone for luteal support in women undergoing in vitro fertilization embryo transfer Mohamed F. Mitwally, M.D., H.C.L.D., a Michael P. Diamond,

More information

10.7 The Reproductive Hormones

10.7 The Reproductive Hormones 10.7 The Reproductive Hormones December 10, 2013. Website survey?? QUESTION: Who is more complicated: men or women? The Female Reproductive System ovaries: produce gametes (eggs) produce estrogen (steroid

More information

ENDOCRINE CHARACTERISTICS OF ART CYCLES

ENDOCRINE CHARACTERISTICS OF ART CYCLES ENDOCRINE CHARACTERISTICS OF ART CYCLES DOÇ. DR. SEBİHA ÖZDEMİR ÖZKAN KOCAELI UNIVERSITY, SCHOOL OF MEDICINE, DEPARTMENT OF OBSTETRICS AND GYNECOLOGY, IVF UNIT 30.04.2014, ANTALYA INTRODUCTION The endocrine

More information

Gonadotropin-releasing hormone agonist reduces the miscarriage rate for pregnancies achieved in women with polycystic ovarian syndrome

Gonadotropin-releasing hormone agonist reduces the miscarriage rate for pregnancies achieved in women with polycystic ovarian syndrome FERTILITY AND STERILITY Copyright e 1993 The American Fertility Society Vol. 59, No.3, March 1993 Printed on acid-free paper in U.S.A. Gonadotropin-releasing hormone agonist reduces the miscarriage rate

More information

Polycystic Ovary Syndrome

Polycystic Ovary Syndrome What is the polycystic ovary syndrome? Polycystic Ovary Syndrome The polycystic ovary syndrome (PCOS) is a clinical diagnosis characterized by the presence of two or more of the following features: irregular

More information

Occult hyperprolactinemia in infertile women

Occult hyperprolactinemia in infertile women FRTILITY AND STRILITY Copyright e 1993 The American Fertility Society Printed on acidfree paper in U. S. A. Occult hyperprolactinemia in infertile women Kunio Asukai MD Tsuguo Uemura M.D Hiroshi Minaguchi

More information

Cobbold Laboratories, University College and Middlesex School of Medicine, Middlesex Hospital, London, United Kingdom

Cobbold Laboratories, University College and Middlesex School of Medicine, Middlesex Hospital, London, United Kingdom FERTILITY AND STERILITY Copyright 1992 The American Fertility Society Printed on acid-free paper in U.S.A. Polycystic ovaries in patients with hypogonadotropic hypogonadism: similarity of ovarian response

More information

Polycystic Ovary Syndrome (PCOS):

Polycystic Ovary Syndrome (PCOS): Polycystic Ovary Syndrome (PCOS): Current diagnosis and treatment Anatte E. Karmon, MD Disclosures- Anatte Karmon, MD No financial relationships to disclose 2 Objectives At the end of this presentation,

More information

Mohammad. Renad zakaria ---

Mohammad. Renad zakaria --- 13 Mohammad Renad zakaria --- Before we start: - I didn t follow the record order, for organizing purposes. - I added extra information from our text box which is Guyton 12 th edition, pages 987-997, actually

More information

Bulent Urman, M.D.* Margo R. Fluker, M.D. Basil Ho Yuen, M.B., Ch.B.t

Bulent Urman, M.D.* Margo R. Fluker, M.D. Basil Ho Yuen, M.B., Ch.B.t FERTILITY AND STERILITY Copyright c 1992 The American Fertility Society Vol. 57, No.6, June 1992 Printed on acid-free paper in U.S.A. The outcome of in vitro fertilization and embryo transfer in women

More information

Polycystic ovarian disease and Endometriosis

Polycystic ovarian disease and Endometriosis Polycystic ovarian disease and Endometriosis Objectives: At the end of this lecture, the student should be able to: Know the clinicopathologic features of endometriosis with special emphasis on: definition,

More information

Female Reproduction 1 and 2: The Menstrual Cycle R.J. Witorsch, Ph.D.

Female Reproduction 1 and 2: The Menstrual Cycle R.J. Witorsch, Ph.D. Female Reproduction 1 and 2: The Menstrual Cycle R.J. Witorsch, Ph.D. OBJECTIVES: At the end of this block of lectures, the student should be able to: 1. Describe the functional anatomy of ovary with particular

More information